Actively Recruiting

Phase Not Applicable
Age: 12Years - 14Years
All Genders
NCT06671106

Efficacy of an Amine and Zinc Lactate - Containing Mouthrinse in the Home-based Treatment of Plaque-induced Gingivitis in Adolescents.

Led by Università degli Studi di Ferrara · Updated on 2025-03-25

150

Participants Needed

1

Research Sites

103 weeks

Total Duration

On this page

Sponsors

U

Università degli Studi di Ferrara

Lead Sponsor

C

Consorzio Futuro in Ricerca

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate if the adjunctive use of an amine and zinc lactate - containing mouthrinse may give significant benefits in the home-based treatment of plaque-induced gingivitis in adolescents. The study is based on the following hypothesis: the periodontal conditions of participants affected by gingivitis will significantly benefit from the implementation of the self-performed plaque control regimen (consisting of manual toothbrush and amine and zinc lactate toothpaste) with an amine and zinc lactate - containing mouthrinse. The benefit is expected to become manifest in terms of impact on clinical periodontal parameters, ecology of the subgingival environment, patient-reported outcomes and oral-health-related quality of life. In other words, gingivitis participants implementing their self-performed oral hygiene with the investigated mouthrinse are expected to assume a closer profile (based on the outcomes listed above) to periodontally healthy subjects when compared to gingivitis participants not using the investigated mouthrinse. One hundred fifty participants (100 adolescents with gingivitis and 50 periodontally healthy adolescents) will be selected for the study. Gingivitis patients will be asked to participate in 5 observation intervals: screening visit, study baseline, and 3 follow-up visits (3 weeks, 3 months, 6 months), while periodontally healthy controls will conclude their participation in the study within the baseline visit. According to the randomization list, at baseline gingivitis patients will receive one of the following home-based oral hygiene regimen: * test intervention (Gt group): manual toothbrush (meridol) and dental floss (meridol) associated with amine and zinc lactate - containing toothpaste (meridol Gum Protection) and amine and zinc lactate - containing mouthrinse (meridol Gum Protection); * control intervention (Gc group): manual toothbrush (meridol) and dental floss (meridol) associated with amine and zinc lactate - containing toothpaste (meridol Gum Protection); All periodontally healthy subjects will be assigned control intervention. At baseline, both gingivitis patients and periodontally healthy subjects will undergo: * assessment of clinical periodontal parameters; * subgingival plaque sampling for microbiological analysis; * assessment of patient-reported outcomes (including oral-health related quality of life) using dedicated questionnaires; Gingivitis subjects will repeat the assessments at 3-week, 3-month, and 6-month follow-up visit. The 6-month proportion of periodontally healthy participants in each gingivitis group (Gt and Gc) will be regarded as the primary outcome of the study. Changes in clinical parameters, subgingival microbial community profile, and scores related to patient-reported outcomes will be regarded as the secondary outcome measures.

CONDITIONS

Official Title

Efficacy of an Amine and Zinc Lactate - Containing Mouthrinse in the Home-based Treatment of Plaque-induced Gingivitis in Adolescents.

Who Can Participate

Age: 12Years - 14Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Systemically healthy
  • Eligible for oral care from Regional Health Service due to low socio-economic status
  • At least 16 fully erupted teeth, excluding third molars
  • Diagnosed with plaque-induced gingivitis or periodontal health according to specified case definitions
  • Willing and able to understand and follow study procedures including questionnaires
Not Eligible

You will not qualify if you...

  • Pregnant or lactating
  • Current smoker
  • Motor or cognitive impairments affecting study compliance
  • Legal guardian unwilling to allow participation or ensure adherence
  • Teeth with developmental defects like enamel pearls or projections
  • Untreated oral lesions including caries or endodontic issues
  • Wearing orthodontic appliances or scheduled for orthodontic treatment incompatible with study timing
  • Use of antibiotics within previous 3 months
  • Use of medications affecting gum size such as phenytoin, sodium valproate, certain calcium channel blockers, or immune-regulating drugs
  • Conditions or medications causing dry mouth such as Sjögren's syndrome, anxiety, poorly controlled diabetes, antihistamines, decongestants, or antidepressants

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Operative Unit of Dentistry

Ferrara, Italy, 44121

Actively Recruiting

Loading map...

Research Team

L

Leonardo Trombelli, Full Professor and Director

CONTACT

R

Roberto Farina, Associate Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here